Ethic Inc’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Ethic Inc’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$683K	Buy	20,171 +566	+3%	+$18.9K	0.01%	830
2026 Q1	$591K	Buy	19,605 +1,478	+8%	+$47.5K	0.01%	813
2025 Q4	$566K	Buy	18,127 +325	+2%	+$8.01K	0.01%	812
2025 Q3	$360K	Sell	17,802 -688	-4%	-$12.1K	0.01%	944
2025 Q2	$310K	Sell	18,490 -1,399	-7%	-$22.6K	0.01%	973
2025 Q1	$304K	Sell	19,889 -35,434	-64%	-$633K	0.01%	931
2024 Q4	$1.22M	Buy	55,323 +17,267	+45%	+$314K	0.02%	545
2024 Q3	$635K	Sell	38,056 -6,320	-14%	-$111K	0.02%	706
2024 Q2	$721K	Buy	44,376 +4,397	+11%	+$67.7K	0.02%	661
2024 Q1	$564K	Buy	39,979 +28,748	+256%	+$362K	0.01%	731
2023 Q4	$117K	Sell	11,231 -176	-2%	-$1.64K	﹤0.01%	1014
2023 Q3	$116K	Buy	+11,407	New	+$106K	﹤0.01%	975
2023 Q2	–	Sell	-14,446	Closed	-$128K	–	1016
2023 Q1	$128K	Buy	+14,446	New	+$143K	0.01%	916
2022 Q4	–	Sell	-13,392	Closed	-$108K	–	930
2022 Q3	$108K	Buy	+13,392	New	+$118K	0.01%	764

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Ethic Inc's TEVA Position: Q2 2026 in Review

Ethic Inc increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 2.9% in Q2 2026, buying an estimated $18.9K and bringing the position to 20,171 shares worth $683K. The position accounts for 0.01% of the portfolio, ranked #830.

Ethic Inc first reported a position in TEVA in Q3 2022 and has held it in 14 quarters since. The position peaked at $1.22M in Q4 2024. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Ethic Inc held 20,171 shares of Teva Pharmaceutical Industries Limited worth $683K as of Q2 2026.
Ethic Inc bought 566 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $18.9K.
Teva Pharmaceutical Industries Limited made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #830 holding.
Ethic Inc first reported a position in Teva Pharmaceutical Industries Limited in Q3 2022 and has held it in 14 quarters since.
Ethic Inc's Teva Pharmaceutical Industries Limited position peaked at $1.22M in Q4 2024.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.